iFAAM: The Impact of Proton-pump Inhibitors (Antacids) on Threshold Dose Distributions

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Food Allergy
Interventions
DRUG

Omeprazole

patients with walnut allergy will be exposed during 5 days before food challenge with Omeprazole

DRUG

Placebo

patients with walnut allergy will be exposed during 5 days before food challenge with Placebo

Trial Locations (2)

8091

University Hospital Zurich, Zurich

Unknown

Hospital Clinico San Carlos, Madrid

All Listed Sponsors
collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

collaborator

University of Nebraska Lincoln

OTHER

collaborator

Region Hovedstadens Apotek

OTHER_GOV

collaborator

University of Manchester

OTHER

collaborator

Hospital San Carlos, Madrid

OTHER

lead

University of Zurich

OTHER

NCT02552537 - iFAAM: The Impact of Proton-pump Inhibitors (Antacids) on Threshold Dose Distributions | Biotech Hunter | Biotech Hunter